Axsome Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
AXSM Nasdaq 8731 https://www.axsome.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axsome Therapeutics Inc

15 Most Black States in the US - Apr 22nd, 2024 1:16 pm
Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting - Apr 15th, 2024 11:00 am
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6 - Apr 10th, 2024 11:00 am
Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study - Apr 2nd, 2024 2:24 pm
Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM) - Apr 2nd, 2024 4:17 am
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder - Apr 1st, 2024 11:00 am
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List - Mar 27th, 2024 11:44 am
30 Countries with the Lowest Depression Rates - Mar 26th, 2024 10:24 am
20 Cloudiest Cities in the U.S., Ranked - Mar 26th, 2024 8:56 am
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients - Mar 25th, 2024 11:00 am
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy - Mar 25th, 2024 10:30 am
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move - Mar 23rd, 2024 10:45 am
Axsome Triumphs Over Major Depressive Disorder With Auvelity - Mar 22nd, 2024 2:00 pm
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi - Mar 20th, 2024 4:12 pm
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder - Mar 19th, 2024 11:00 am
11 Oversold NASDAQ Stocks To Buy Right Now - Mar 13th, 2024 7:32 pm
Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference - Mar 5th, 2024 12:00 pm
Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference - Feb 27th, 2024 12:00 pm
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 - Feb 26th, 2024 8:04 pm
3 Biotech Stocks to Buy and Hold for the Next 10 Years - Feb 26th, 2024 1:50 pm